IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO. (Q35845197)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 May 2015

Language	Label	Description	Also known as
English	IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.	scientific article published on 12 May 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO. (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

World Health Organization

0 references

Andreas von Deimling

19

object named as

Andreas von Deimling

0 references

Christel Herold-Mende

17

object named as

Christel Herold-Mende

0 references

Andreas Unterberg

14

object named as

Andreas Unterberg

0 references

object named as

Felix Sahm

7

0 references

Volker Hovestadt

object named as

Volker Hovestadt

5

0 references

Michael Platten

object named as

Michael Platten

15

0 references

16

object named as

Wolfgang Wick

1 reference

Europe PubMed Central

10 August 2017

PMC publication ID

4

object named as

David Capper

1 reference

Europe PubMed Central

10 August 2017

PMC publication ID

Daniel Schrimpf

3

object named as

Daniel Schrimpf

1 reference

Europe PubMed Central

10 August 2017

PMC publication ID

Andrey Korshunov

9

object named as

Andrey Korshunov

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Jaap C Reijneveld

12

object named as

Jaap C Reijneveld

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

1

object named as

David E Reuss

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Kenneth D Aldape

18

object named as

Kenneth Aldape

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

2

object named as

Yasin Mamatjan

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Annekathrin Kratz

6

object named as

Annekathrin Kratz

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Christian Koelsche

8

object named as

Christian Koelsche

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

10

object named as

Adriana Olar

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Pieter Wesseling

13

object named as

Pieter Wesseling

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

author name string

Christian Hartmann

11

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

publication date

12 May 2015

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Acta Neuropathologica

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

129

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

867-873

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

Mutational landscape and clonal architecture in grade II and III gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

IDH1 and IDH2 mutations in gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

Analysis of the IDH1 codon 132 mutation in brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

The WHO classification of tumors of the nervous system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

Supratentorial low-grade astrocytomas in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

Grading of astrocytomas. A simple and reproducible method.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

27 July 2018

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

24 September 2018

ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

24 September 2018

Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

24 September 2018

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

24 September 2018

No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

24 September 2018

IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

24 September 2018

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

24 September 2018

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500039

24 September 2018

Identifiers

10.1007/S00401-015-1438-8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35845197&oldid=2197842151"